125 related articles for article (PubMed ID: 26070487)
21. Distinct effects of annexin A7 and p53 on arachidonate lipoxygenation in prostate cancer cells involve 5-lipoxygenase transcription.
Torosyan Y; Dobi A; Naga S; Mezhevaya K; Glasman M; Norris C; Jiang G; Mueller G; Pollard H; Srivastava M
Cancer Res; 2006 Oct; 66(19):9609-16. PubMed ID: 17018618
[TBL] [Abstract][Full Text] [Related]
22. Functional characterization of vitamin D responding regions in the human 5-Lipoxygenase gene.
Seuter S; Väisänen S; Rådmark O; Carlberg C; Steinhilber D
Biochim Biophys Acta; 2007 Jul; 1771(7):864-72. PubMed ID: 17500032
[TBL] [Abstract][Full Text] [Related]
23. The coding sequence mediates induction of 5-lipoxygenase expression by Smads3/4.
Seuter S; Sorg BL; Steinhilber D
Biochem Biophys Res Commun; 2006 Oct; 348(4):1403-10. PubMed ID: 16919603
[TBL] [Abstract][Full Text] [Related]
24. Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damage.
Kelley LL; Hicks GG; Hsieh FF; Prasher JM; Green WF; Miller MD; Eide EJ; Ruley HE
Oncogene; 1998 Sep; 17(9):1119-30. PubMed ID: 9764822
[TBL] [Abstract][Full Text] [Related]
25. p53 induction and activation of DDR1 kinase counteract p53-mediated apoptosis and influence p53 regulation through a positive feedback loop.
Ongusaha PP; Kim JI; Fang L; Wong TW; Yancopoulos GD; Aaronson SA; Lee SW
EMBO J; 2003 Mar; 22(6):1289-301. PubMed ID: 12628922
[TBL] [Abstract][Full Text] [Related]
26. Decoy receptor 2 (DcR2) is a p53 target gene and regulates chemosensitivity.
Liu X; Yue P; Khuri FR; Sun SY
Cancer Res; 2005 Oct; 65(20):9169-75. PubMed ID: 16230375
[TBL] [Abstract][Full Text] [Related]
27. p53-mediated repression of DNA methyltransferase 1 expression by specific DNA binding.
Peterson EJ; Bögler O; Taylor SM
Cancer Res; 2003 Oct; 63(20):6579-82. PubMed ID: 14583449
[TBL] [Abstract][Full Text] [Related]
28. Gene expression profiling of isogenic cells with different TP53 gene dosage reveals numerous genes that are affected by TP53 dosage and identifies CSPG2 as a direct target of p53.
Yoon H; Liyanarachchi S; Wright FA; Davuluri R; Lockman JC; de la Chapelle A; Pellegata NS
Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15632-7. PubMed ID: 12438652
[TBL] [Abstract][Full Text] [Related]
29. Trichostatin A and structurally related histone deacetylase inhibitors induce 5-lipoxygenase promoter activity.
Klan N; Seuter S; Schnur N; Jung M; Steinhilber D
Biol Chem; 2003 May; 384(5):777-85. PubMed ID: 12817474
[TBL] [Abstract][Full Text] [Related]
30. 5-lipoxygenase antagonizes genotoxic stress-induced apoptosis by altering p53 nuclear trafficking.
Catalano A; Caprari P; Soddu S; Procopio A; Romano M
FASEB J; 2004 Nov; 18(14):1740-2. PubMed ID: 15375079
[TBL] [Abstract][Full Text] [Related]
31. Ku autoantigen (DNA helicase) is required for interleukins-13/-4-induction of 15-lipoxygenase-1 gene expression in human epithelial cells.
Kelavkar UP; Wang S; Badr KF
Genes Immun; 2000; 1(4):237-50. PubMed ID: 11196700
[TBL] [Abstract][Full Text] [Related]
32. p53-Dependent p21 mRNA elongation is impaired when DNA replication is stalled.
Mattia M; Gottifredi V; McKinney K; Prives C
Mol Cell Biol; 2007 Feb; 27(4):1309-20. PubMed ID: 17158927
[TBL] [Abstract][Full Text] [Related]
33. The histone deacetylase inhibitor trichostatin A mediates upregulation of 5-lipoxygenase promoter activity by recruitment of Sp1 to distinct GC-boxes.
Schnur N; Seuter S; Katryniok C; Rådmark O; Steinhilber D
Biochim Biophys Acta; 2007 Oct; 1771(10):1271-82. PubMed ID: 17894944
[TBL] [Abstract][Full Text] [Related]
34. Mitofusin-2 is a novel direct target of p53.
Wang W; Cheng X; Lu J; Wei J; Fu G; Zhu F; Jia C; Zhou L; Xie H; Zheng S
Biochem Biophys Res Commun; 2010 Oct; 400(4):587-92. PubMed ID: 20804729
[TBL] [Abstract][Full Text] [Related]
35. Additive effect between NF-kappaB subunits and p53 protein for transcriptional activation of human p53 promoter.
Benoit V; Hellin AC; Huygen S; Gielen J; Bours V; Merville MP
Oncogene; 2000 Sep; 19(41):4787-94. PubMed ID: 11032029
[TBL] [Abstract][Full Text] [Related]
36. p53-mediated downregulation of H ferritin promoter transcriptional efficiency via NF-Y.
Faniello MC; Di Sanzo M; Quaresima B; Baudi F; Di Caro V; Cuda G; Morrone G; Del Sal G; Spinelli G; Venuta S; Costanzo F
Int J Biochem Cell Biol; 2008; 40(10):2110-9. PubMed ID: 18372207
[TBL] [Abstract][Full Text] [Related]
37. The potential role of DFNA5, a hearing impairment gene, in p53-mediated cellular response to DNA damage.
Masuda Y; Futamura M; Kamino H; Nakamura Y; Kitamura N; Ohnishi S; Miyamoto Y; Ichikawa H; Ohta T; Ohki M; Kiyono T; Egami H; Baba H; Arakawa H
J Hum Genet; 2006; 51(8):652-664. PubMed ID: 16897187
[TBL] [Abstract][Full Text] [Related]
38. UBTD1 induces cellular senescence through an UBTD1-Mdm2/p53 positive feedback loop.
Zhang XW; Wang XF; Ni SJ; Qin W; Zhao LQ; Hua RX; Lu YW; Li J; Dimri GP; Guo WJ
J Pathol; 2015 Mar; 235(4):656-67. PubMed ID: 25382750
[TBL] [Abstract][Full Text] [Related]
39. The Intracellular Localisation and Phosphorylation Profile of the Human 5-Lipoxygenase Δ13 Isoform Differs from That of Its Full Length Counterpart.
Allain EP; Boudreau LH; Flamand N; Surette ME
PLoS One; 2015; 10(7):e0132607. PubMed ID: 26173130
[TBL] [Abstract][Full Text] [Related]
40. p53 upregulates death receptor 4 expression through an intronic p53 binding site.
Liu X; Yue P; Khuri FR; Sun SY
Cancer Res; 2004 Aug; 64(15):5078-83. PubMed ID: 15289308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
